Noninvasive Assessment of Liver Fibrosis

Digestive Diseases

Volumn 33, Issue 4, 2015, Pages 498-503

  Castera, Laurent ^a  

^a CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Acoustic radiation force impulse imaging; Liver fibrosis; Shear wave elastography

Indexed keywords

BIOLOGICAL MARKER;

ACOUSTIC RADIATION FORCE IMPULSE IMAGING; ANTIVIRAL THERAPY; ARTICLE; CANCER SCREENING; CHRONIC HEPATITIS C; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DIAGNOSTIC IMAGING EQUIPMENT; DIGESTIVE TRACT PARAMETERS; DISEASE COURSE; DISEASE SEVERITY; ELASTOGRAPHY; ESOPHAGUS VARICES; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER STIFFNESS; METHODOLOGY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROGNOSIS; SHEAR WAVE ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; BLOOD; COMPLICATION; ELASTICITY; LIVER; LIVER CIRRHOSIS; LIVER DISEASE; PATHOLOGY; PROCEDURES; REPRODUCIBILITY;

BIOMARKERS; DISEASE PROGRESSION; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 84937434069     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000374097     Document Type: Article

References (70)

1. Castera L, Pinzani M: Non-invasive assessment of liver fibrosis: are we ready? Lancet 2010; 375: 1419-1420.
2. Castera L: Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012; 142: 1293-1302.
3. Imbert-Bismut F, Ratziu V, Pieroni L, et al: Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075.
4. Forns X, Ampurdanes S, Llovet JM, et al: Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986-992.
5. Wai CT, Greenson JK, Fontana RJ, et al: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526.
6. Patel K, Gordon SC, Jacobson I, et al: Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004; 41: 935-942.
7. Leroy V, Monier F, Bottari S, et al: Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 2004; 99: 271-279.
8. Rosenberg WM, Voelker M, Thiel R, et al: Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004; 127: 1704-1713.
9. Sud A, Hui JM, Farrell GC, et al: Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology 2004; 39: 1239-1247.
10. Adams LA, Bulsara M, Rossi E, et al: Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005; 51: 1867-1873.
11. Cales P, Oberti F, Michalak S, et al: A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005; 42: 1373-1381.
12. Lok AS, Ghany MG, Goodman ZD, et al: Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005; 42: 282-292.
13. Islam S, Antonsson L, Westin J, et al: Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scand J Gastroenterol 2005; 40: 867-872.
14. Hui AY, Chan HL, Wong VW, et al: Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005; 100: 616-623.
15. Zeng MD, Lu LG, Mao YM, et al: Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology 2005; 42: 1437-1445.
16. Fontana RJ, Kleiner DE, Bilonick R, et al: Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection. Hepatology 2006; 44: 925-935.
17. Koda M, Matunaga Y, Kawakami M, et al: FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007; 45: 297-306.
18. Vallet-Pichard A, Mallet V, Nalpas B, et al: FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection: comparison with liver biopsy and FibroTest. Hepatology 2007; 46: 32-36.
19. Angulo P, Hui JM, Marchesini G, et al: The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007; 45: 846-854.
20. Harrison SA, Oliver D, Arnold HL, et al: Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008; 57: 1441-1447.
21. Fontana RJ, Goodman ZD, Dienstag JL, et al: Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology 2008; 47: 789-798.
22. Sandrin L, Fourquet B, Hasquenoph JM, et al: Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-1713.
23. Roulot D, Czernichow S, Le Clesiau H, et al: Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48: 606-613.
24. Castera L, Forns X, Alberti A: Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-847.
25. Fraquelli M, Rigamonti C, Casazza G, et al: Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-973.
26. Castera L, Foucher J, Bernard PH, et al: Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010; 51: 828-835.
27. Myers RP, Pomier-Layrargues G, Kirsch R, et al: Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012; 55: 199-208.
28. Castera L, Pinzani M: Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 2010; 59: 861-866.
29. Mederacke I, Wursthorn K, Kirschner J, et al: Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int 2009; 29: 1500-1506.
30. Arena U, Platon ML, Stasi C, et al: Liver stiffness is influenced by a standardized meal in patients with chronic HCV hepatitis at different stages of fibrotic evolution. Hepatology 2013; 58: 65-72. Disease. BMC Gastroenterol 2007; 7: 40.
31. Lin ZH, Xin YN, Dong QJ, et al: Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 2011; 53: 726-736.
32. Degos F, Perez P, Roche B, et al: Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol 2010; 53: 1013-1021.
33. Castera L, Vilgrain V, Angulo P: Non-invasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol 2013; 10: 666-675.
34. Castera L, Vergniol J, Foucher J, et al: Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350.
35. Ziol M, Handra-Luca A, Kettaneh A, et al: Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
36. Corpechot C, El Naggar A, Poujol-Robert A, et al: Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006; 43: 1118-1124.
37. Ganne-Carrie N, Ziol M, de Ledinghen V, et al: Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 1511-1517.
38. Foucher J, Chanteloup E, Vergniol J, et al: Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-408.
39. Coco B, Oliveri F, Maina AM, et al: Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007; 14: 360-369.
40. Arena U, Vizzutti F, Abraldes JG, et al: Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008; 57: 1288-1293.
41. Yoneda M, Yoneda M, Mawatari H, et al: Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008; 40: 371-378.
42. Nobili V, Vizzutti F, Arena U, et al: Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008; 48: 442-448.
43. Nahon P, Kettaneh A, Tengher-Barna I, et al: Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 2008; 49: 1062-1068.
44. Nguyen-Khac E, Chatelain D, Tramier B, et al: Assessment of asymptomatic liver fibrosis in alcoholic patients using Fibroscan: prospective comparison with 7. non-invasive laboratory tests. Aliment Pharmacol Ther 2008: 1188-1198.
45. Marcellin P, Ziol M, Bedossa P, et al: Noninvasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29: 242-247.
46. Chan HL, Wong GL, Choi PC, et al: Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009; 16: 36-44.
47. Wong VW, Vergniol J, Wong GL, et al: Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-462.
48. Zarski JP, Sturm N, Guechot J, et al: Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 2012; 56: 55-62.
49. Shaheen AA, Wan AF, Myers RP: FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 2007; 102: 2589-2600.
50. Talwalkar JA, Kurtz DM, Schoenleber SJ, et al: Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2007; 5: 1214-1220.
51. Friedrich-Rust M, Ong MF, Martens S, et al: Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-974.
52. Tsochatzis EA, Gurusamy KS, Ntaoula S, et al: Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54: 650-659.
53. Friedrich-Rust M, Nierhoff J, Lupsor M, et al: Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 2012; 19:e212-e219.
54. Huwart L, Sempoux C, Vicaut E, et al: Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008; 135: 32-40.
55. Ferraioli G, Tinelli C, Dal Bello B, et al: Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology 2012; 56: 2125-2133.
56. Sebastiani G, Vario A, Guido M, et al: Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006; 44: 686-693.
57. Sebastiani G, Halfon P, Castera L, et al: SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49: 1821-1827.
58. Poynard T, Ingiliz P, Elkrief L, et al: Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS One 2008; 3:e3857.
59. Boursier J, de Ledinghen V, Zarski JP, et al: A new combination of blood test and Fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol 2011; 106: 1255-1263.
60. Castera L, Sebastiani G, Le Bail B, et al: Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol 2010; 52: 191-198.
61. Boursier J, de Ledinghen V, Zarski JP, et al: Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive. Hepatology 2012; 55: 58-67.
62. Castera L, Le Bail B, Roudot-Thoraval F, et al: Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009; 50: 59-68.
63. Carrion JA, Navasa M, Bosch J, et al: Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006; 12: 1791-1798.
64. Vizzutti F, Arena U, Romanelli RG, et al: Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297.
65. Castera L, Pinzani M, Bosch J: Non invasive evaluation of portal hypertension using transient elastography. J Hepatol 2012; 56: 696-703.
66. Vergniol J, Foucher J, Terrebonne E, et al: Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140: 1970-1979.
67. Robic MA, Procopet B, Metivier S, et al: Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol 2011; 55: 1017-1024.
68. Ngo Y, Munteanu M, Messous D, et al: A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 2006; 52: 1887-1896.
69. Naveau S, Gaude G, Asnacios A, et al: Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009; 49: 97-105.
70. Parkes J, Roderick P, Harris S, et al: Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut 2010; 59: 1245-1251.